Oncology Data Advisor

Treatment for systemic mastocytosis (SM) has evolved fast—are your management strategies keeping up? Join Dr. Castells as she dives into the latest advances in SM therapy, including how and when to leverage tyrosine kinase inhibitors, and how to collaborate across specialties to tailor care that truly meets each patient’s needs. Packed with practical pearls and forward‑looking insights, this episode will help you elevate symptom control, safety, and quality of life for your patients. Listen now before this accredited activity expires on April 15! Click here to claim your CME/NCPD/AAPA credit: bit.ly/4cxzgAK